Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. It develops EDAPT, a differentiated technology platform designed to explore the new and expanding Dark Antigen repertoire and to identify and assess its tumor specificity and immunogenic potential to combat cancers.